Heidelberg Pharma AG

€2.14As of Sun 8 Nov 2026, 12:00 UTC
XETRA:HPHAHealthcare
Country Germany
PE (Fwd) •••
TSR 10Y CAGR 3.42%
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.78
PE TTM —
TSR TTM (27.95%)
Mkt cap €100.1M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
€2.32
8.57%
(80.81%)
Hold 0|9|1|1|8
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.03
0.03
0.03
0.03
20.48%
9.77%
9.92%
10.80%
Revenue€M
5.470
5.529
5.719
5.553
13.57%
10.65%
13.01%
4.58%
Peers (US$112.4M)
Cap (US$)
PE
192.3M
—
134.3M
—
112.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.483
(0.099)
(0.095)
EBIT/Intx
4.069
0.199
0.206
Own earn%
4.43
(193.74)
(129.05)
Sh yield%
19.54
19.51
16.55
Owners
Insiders/Inst%
1.32
80.31
Short interest%
0.86
SBC / revenue%
3.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
8–13
$1 testx
0.3
Incr. ROIC%
4